Celldex Therapeutics, Inc.
Hampton, NJ Doing business as Celldex Therapeutics Inc. Celldex Therapeutics, Inc.
- UEI
- EGSNNDJBMAG5
- CAGE
- 3MAZ1
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 53 I-78 Frontage Rd #220, Hampton, NJ 08827, USA
- Website
- celldex.com
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Immune modulation of radiation therapy with FLT3 ligand | National Cancer Institute | $6,225,715 | |
| CDX-301 and plerixafor combination in stem cell mobilization for transplantation | National Institutes of Health | $110,528 | |
| Other functions - r & d biomedical (basic research) | National Cancer Institute | $199,398 | |
| Dendritic cell-targeted HIV vaccine product | National Institutes of Health | $297,572 | |
| Dendritic cell-targeted HIV vaccine product | National Institutes of Health | $1,888,108 |
Quick answers
What is Celldex Therapeutics, Inc.'s UEI?
Celldex Therapeutics, Inc.'s Unique Entity ID (UEI) in SAM.gov is EGSNNDJBMAG5.
What is Celldex Therapeutics, Inc.'s CAGE code?
Celldex Therapeutics, Inc.'s CAGE code is 3MAZ1.
What is Celldex Therapeutics, Inc.'s primary NAICS code?
Celldex Therapeutics, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Celldex Therapeutics, Inc. located?
Celldex Therapeutics, Inc.'s physical address in SAM.gov is 53 I-78 Frontage Rd #220, Hampton, NJ 08827, USA.
Is Celldex Therapeutics, Inc. registered in SAM.gov?
Yes. Celldex Therapeutics, Inc.'s SAM.gov registration is active through June 3, 2027.
What is Celldex Therapeutics, Inc.'s most recent federal award?
Celldex Therapeutics, Inc.'s most recent federal grant award is Immune modulation of radiation therapy with FLT3 ligand (R44CA192435), from National Cancer Institute, on September 1, 2015.
On GovTribe
See Celldex Therapeutics, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors